Twist Bioscience's reported and projected revenues exceeding estimates indicate strong financial performance and potential growth, likely leading to a positive short-term impact on its stock price. The surpassing of revenue estimates for Q3 and the optimistic projection for Q4 suggest operational efficiency and market demand for its offerings, which are key drivers for investor confidence and stock valuation.